FDA Inspection 1110235 — SoliPharma B.V.

SoliPharma B.V. — FEI 3013167880

The FDA completed an inspection of SoliPharma B.V. on November 15, 2019 in Oudenbosch. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2019
Fiscal Year
2020
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Oudenbosch (Netherlands)

Citations

IDCFRDescription
1539521 CFR 111.10(b)(5)Gloves
1553221 CFR 111.255(b)Batch record - complete
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1586921 CFR 111.75(c)Specifications met - verify; finished batch